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Abstract 
Background: Type 2 diabetes (T2D) is one of the most psychologically demanding chronic medical illness in adult. 
Comorbidity between diabetes and depression is quite common, but most studies were based on developed country 
sample. Limited data exists to document biopsychosocial predictors of depressive symptoms in Ethiopian patients. 
Therefore, the aim of the study was to describe the association of depressive symptoms and T2D and explore the 
potential underlying associated biopsychosocial risk factors.
Methods: Institution based cross-sectional study was conducted on 276 patient with T2D at diabetic clinic, Black 
Lion General Specialized Hospital in Ethiopia. Patients were selected using systematic random sampling technique. 
Depressive symptoms score, which constructed from a validated nine-item Patient Health Questionnaire (PHQ-9), was 
an outcome variable. Finally, significant associated factors were identified using multiple linear regression analysis 
with backward elimination procedure. Statistical Package for Social Science (SPSS) version 22.0 (IBM SPSS Corp.) was 
used to perform all analysis.
Results: Total of 264 patient data was analyzed with 95.7% response rate. Patients mean (SD) current age and 
age at diagnosis was 55.9 (10.9) and 43.9 (10.9) years, respectively. Patients waist circumference (mean ± SD) was 
98.9 ± 11.1 cm. The average PHQ-9 score was 4.9 (SD 4.1) and fasting blood glucose was 166.4 (SD 73.2). Marital status 
(divorced), occupation (housewife), diabetic complication (nephropathy), negative life event in the last six months, 
and poor social support significantly associated with increased mean PHQ-9 score after adjustment for covariates. 
Whereas not fearing diabetic-related complication and death significantly lower mean PHQ-9 score.
Conclusion: Biopsychosocial variables including marital status, negative life event in the last 6 months, occupation, 
diabetic complication, and poor social support significantly increase average depressive symptoms score. Evidence-
based intervention focusing on these identified biopsychosocial factors are necessary to prevent the development of 
depressive symptoms.
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Background
Diabetes mellitus (DM) has been affecting millions of 
people from all over the world. In 2013, 382 million peo-
ple had diabetes; this estimate is expected to rise to 592 
million by 2035 [1, 2]. More than 77% of morbidity and 
88% of mortality due to DM occur in low and middle-
income countries. In Ethiopia, the prevalence of dia-
betes was 0.34–5.0% [3, 4]. During the last decades, the 
comorbidity of mental disorders with chronic health 
conditions have emerged as a topic of considerable clini-
cal and policy interest. Due to complex nature of disease 
pathophysiology, cause, and treatment, type 2 diabe-
tes (T2D) is considered one of the most psychologically 
demanding chronic medical illness in an adult patient [5, 
6]. In spite of this, up to 45% of cases of comorbid men-
tal disorder and severe psychological distress were poorly 
identified and inadequately treated among patients with 
diabetes in sub-Saharan Africa [7, 8]. The prevalence of 
psychiatric disorders in diabetic patients may reach 84% 
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Based on a study report by Ana Claudia and colleagues 
the most prevalent comorbid disorders were generalized 
anxiety disorder (21%), dysthymia (15%), social phobia 
(7%), lifelong depression (3.5%), panic disorder (2.5%), 
and risk of suicide (2%) [10]. Depression was among the 
most common neuropsychiatric disorders in patients 
with T2D [8].
Thomas Willis, British physician, recognized the asso-
ciation between depression and diabetes since 17th cen-
tury [11]. Epidemiologically, one in every four patient with 
T2D develops clinically significant depression [12]. The 
estimated lifetime prevalence of depression was higher in 
women (21%) [13]. The prevalence of depression in T2D 
patient was 5.5–49.6% [10, 14–22]. Even though most 
studies was on Western samples, there have been emerg-
ing studies in developing countries including Ethiopia [16, 
23–25]. A cross-sectional study by Erkie et  al. described 
depression was diagnosed in 64.8% of T2D outpatient 
[23]. The exact mechanisms of relationship are elusive, and 
models for the associated factors are multidimensional.
Engel’s [26] biopsychosocial model of health and ill-
ness is a model for clinical practice and research for psy-
chologists, nurses, physicians, and social workers [27]. 
American Psychiatric Association and American Board 
of Psychiatry and Neurology have officially approved 
Engel’s model [28, 29]. According to Engel’s model any 
disease such as depression [30–33] caused by biological 
(physiological or genetic predispositions), psychologi-
cal (health beliefs and lifestyle) and social factors (family 
relationships, socioeconomic status, and social support). 
The model reveals the interaction of this factor to create 
patient’s state of mind and body [34, 35] (Fig. 1).
T2D patients were poorly diagnosed and inadequately 
treated in sub-Saharan Africa [8]. In general, the data is 
limited, and the conclusion seems inadequate to iden-
tify biopsychosocial risk factors of depressive symptoms 
in Ethiopian diabetic patients. In the present study, we 
aimed to describe the association of depressive symp-




We conducted an institution based cross-sectional study 
among T2D outpatients on regular follow-up at Black 
Lion General Specialized Hospital from February to April 
2013.
Determinants and covariables
The outcome variable was depressive symptoms score. 
The explanatory variables were biological factors: age, 
sex, comorbid disease, diabetic complication, diabetic 
treatment, fasting blood glucose, body mass index; psy-
chological factors: unemployment, financial stress, nega-
tive life event, polypharmacy, smoking, lack of regular 
physical activity, perceived fear of complication and 
death, perceived high healthcare cost; and social fac-
tors: socioeconomic status, educational status, marital 
status, major family conflict, poor social support. We 
defined polypharmacy as taking greater than or equal 
to four prescribed medications per day. Poor social sup-
port was defined as lack of support or care from the fam-
ily, friends, and neighbors. Another studied factor was, 
which referred to an event such as accident and death in 
the last six months that leads to a feeling of stress or anxi-
ety, negative life event. Perceived fear of complication 
and death was defined as individual feeling or opinion 
about his/her illness and related complication. Perceived 
high healthcare cost was defined as personal feeling or 
idea about the expense of diabetes treatment. Physical 
activity was defined as doing any aerobic exercise 3–5 
times per week at least for 30 min.
Sampling and data collection
Patients were chosen based on three criteria: T2D diag-
nosis at least for one year, age  ≥20  years old, capable 
of independent communication, and signed written 
informed consent. Patients treated for depression, or 
other psychological illnesses (e.g. anxiety or personal-
ity disorders) were excluded. Systematic random sam-
pling technique was used to reach individual patients. 
The data was collected by two trained Nurses from every 
three patients (sampling interval/k/  =  3). All biological 
(physiological) data was collected from patients’ medical 
chart. Face-to-face interview was conducted in the treat-
ing private clinics to collect psychological and social data. 
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Fig. 1 Engle’s biopsychosocial model of health and disease adapted 
for our study
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interest to participate and a shortage of time. In total 264 
cases were included in the final analysis.
Measuring depressive symptoms
Depression, which refers to symptoms experienced dur-
ing the last two weeks, was measured by Patient Health 
Questionnaire (PHQ-9) [36, 37]. The PHQ-9 includes 
nine items with individual score ranges from 0 (not at all) 
to 3 (nearly every day). The total sum score ranging from 
0 to 27. PHQ-9 scores with cut-off point 5, 10, 15 and 20 
represent mild, moderate, moderately severe, and severe 
depression, respectively [36]. In our study, T2D patients’ 
depression status was measured by administering a vali-
dated Ethiopian version PHQ-9 questionnaire. Gelaye 
and colleagues showed PHQ-9 internal reliability of 0.81, 
test re-test reliability of 0.92, sensitivity of 86%, and spec-
ificity of 67% [38].
Statistical analysis
First of all, four cases were not included in our analy-
sis because of outlying PHQ-9 score (≥20). Descriptive 
statistics including mean, standard deviation, percent-
age, and cross-tabulation was performed for all patient 
parameters. Univariate linear regression analysis was 
performed per each biopsychosocial variable. The full 
model of multiple linear regression included all signifi-
cant variables. Finally, significantly associated factors 
were identified by backward elimination procedure. QQ-
plot, histogram and scatter plot of ‘Standardized residu-
als’ against ‘Standardized predicted values’ were used to 
check the assumptions of linearity of relationships, nor-
mal distribution and homoscedasticity of residuals for 
the final model. Two-tailed test at 5% level of significance 
was used for all association test. Statistical Package for 
Social Science (SPSS) version 22.0 (IBM SPSS Corp.) was 




Total of 264 patient data was analyzed with 95.7% 
response rate. Patients mean (SD) current age and age at 
diagnosis was 55.9 (10.9) and 43.9 (10.9) years, respec-
tively. Also, patients waist circumference (mean  ±  SD) 
was 98.9 ± 11.1 cm while patients family median monthly 
income was 750 Ethiopian Birr (651–1400). The average 
PHQ-9 score was 4.9 (SD 4.1) and fasting blood glucose 
was 166.4 (SD 73.2). The mean  ±  SD of PHQ-9 score 
was 6 ± 4.7 in female, 7.3 ± 5.7 in divorced, 6.6 ± 4.5 in 
educational level of grade 1–8, and 6.77 ± 5.3 in house-
wife patient. The mean ± SD of number of comorbid dis-
eases and body mass index was 1.1 ± 0.9 and 25.4 ± 3.7, 
respectively (Table 1).
Univariate linear regression test of association
Patient mean PHQ-9 score was significantly increased 
by 1.4 (95% CI 0.4–2.4) in female, 2.2 (95% CI 0.7–3.7) 
in divorced, and 1.7 (95% CI 0.4–3.0) in housewife. One 
unit increase in number of comorbidities was associated 
with a 0.6 unit (p = 0.04) increase in PHQ-9 score. One 
unit increase in number of diabetic complication was 
associated with a 0.5 unit (p = 0.02) increase in PHQ-9 
score. Increased age at diagnosis (i.e. late-onset diabetes), 
increased monthly family income, high educational sta-
tus (college or university), doing physical activity and not 
fearing diabetes-related complication and death signifi-
cantly lower mean PHQ-9 score (Table 2).
Multiple linear regression tests of association
All significant biopsychosocial variables, Table  3, in the 
final model together explained about 25.3% of the vari-
ability of patients PHQ-9 score. Divorce, housewife, dia-
betic nephropathy, negative life event, and poor social 
support were significant risk factors associated with 
increased PHQ-9 score after adjustment for covariates. 
However, not fearing diabetic-related complications and 
death significantly lower PHQ-9 score. Additional file 1: 
Table S1 presented all confounding factors.
The final model reasonably fulfilled three assump-
tions: linearity of relationship (Additional file  1: Figure 
S1), homoscedasticity (Additional file  1: Figure S2), and 
normal distribution (Additional file 1: Figure S3) assump-
tions. For further information, residual statistics table 
(Additional file 1: Table S2) accompanied as well.
Discussion
This study examined biopsychosocial factors associated 
with comorbid depression in patients with T2D.
In this study diabetic nephropathy, biologic factor consist-
ent with other studies [39, 40], significantly increased the 
risk of depression. However, several other studies recog-
nized gender [16, 17, 21, 41–43], age [16, 17, 20, 44, 45], dia-
betic treatment [21, 46, 47], body mass index [21, 48], fasting 
plasma glucose [17–19, 49, 50], poor diabetes mellitus con-
trol [15], number of comorbidities [21, 48, 51, 52], diabetic 
complications [16, 17, 53, 54], duration of diabetes [23, 45], 
age at diabetes diagnosis [55, 56], large waist circumference 
[39], diabetic retinopathy [40], diabetic neuropathy [39, 40, 
57, 58], cardiovascular disease comorbidity [39, 40, 59, 60], 
sexual dysfunction [40] were physiologic (biologic) risk fac-
tors that significantly associated with depression.
In this study occupational status (housewife) and expe-
riencing negative life events, psychological factors, sig-
nificantly increased risk of depression in line with other 
earlier studies [39, 57, 61]. Interestingly, our final model 
uncovered not fearing diabetic related complications and 
death significantly lower risk of depression. On the other 
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hand, depression was associated with diabetes treatment 
complexity [62], experienced loss of business or crop 
failure [16], unemployment [44, 47, 52], lack of regular 
physical activity [14, 21, 47], smoking [21, 48, 63], finan-
cial stress [39, 57, 61], poor quality of life [61, 64], and 
polypharmacy [39, 65].
Finally, we confirmed marital status (divorce) and poor 
social support, social factors similar to previous studies 
[19, 21, 57], significantly increased risk of depression. 
Contrariwise, urban residence [59], low socioeconomic 
status [19, 20, 42, 47, 66], lower educational status [23, 
47, 49, 52], marital status [15, 17, 19, 21, 24, 44], major 
Table 1 Distribution of patients PHQ-9 score and fasting blood glucose by biopsychosocial characteristics of patients
SD standard deviation




Gender, female 140 (53.0) 6.0 (4.77) 181.30 (79.94)
Residence, Addis Ababa 228 (86.4) 5.07 (4.35) 166.13 (71.78)
Marital status Married 183 (69.3) 4.68 (4.17) 164.4 (70.67)
Divorced 24 (9.1) 7.3 (5.75) 188.94 (94.31)
Widowed 48 (18.2) 5.92 (4.73) 162.04 (66.48)
Religion Orthodox christian 213 (80.7) 5.48 (4.74) 167.64 (72.76)
Muslim 24 (9.1) 3.71 (3.14) 170.04 (92.81)
Other religion 5 (1.9) 4.67 (4.04) 159.63 (61.18)
Ethnicity Amhara 151 (57.2) 5.23 (4.71) 168.71 (74.05)
Oromo 40 (15.2) 5.8 (4.54) 165.65 (77.42)
Others 19 (7.2) 4.93 (4.33) 164.36 (70.94)
Educational status No formal education 51 (19.4) 6.1 (5.17) 179.57 (81.79)
Grade 1–8 16 (6.1) 6.63 (4.53) 171.11 (78.94)
Grade 9–12 59 (22.3) 4.42 (4.08) 165.66 (63.11)
College/university 89 (33.7) 4.26 (4.25) 157.81 (70.59)
Occupation Civil servant 47 (17.8) 4.74 (4.71) 172.51 (59.36)
House wife 47 (17.8) 6.77 (5.26) 183.45 (71.56)
Private worker 38 (14.4) 4.29 (3.84) 162.95 (93.59)
Pensioned 58 (22.0) 4.69 (4.48) 142.0 (56.18)
No employment 48 (18.2) 5.85 (4.14) 172.9 (80.15)
Others 16 (6.1) 4.81 (4.53) 178.54 (79.98)
Diabetes treatment Single insulin injection 108 (40.9) 5.78 (4.99) 162.44 (83.22)
Combined insulin injection 12 (4.5) 5.92 (5.14) 218.17 (104.57)
Insulin plus oral hypoglycemic 30 (11.4) 5.23 (3.61) 167.67 (58.89)
Oral hypoglycemic 114 (43.2) 4.65 (4.29) 165.85 (61.25)
Comorbid disease (N = 180) Cardiovascular disease 141 (78.3) 5.57 (4.68) 162.81 (68.43)
Respiratory disease 17 (9.4) 5.41 (4.43) 151.53 (66.82)
Renal disease 13 (7.2) 5.54 (4.31) 158.46 (58.13)
Neurologic disease 4 (2.2) 6.75 (6.13) 131.5 (35.48)
Others comorbidity 80 (44.4) 6.04 (5.09) 174.59 (72.01)
Diabetic complication (N = 201) Diabetic retinopathy 140 (69.7) 5.79 (4.67) 166.76 (70.51)
Diabetic nephropathy 69 (34.3) 7.09 (5.16) 176.43 (72.36)
Diabetic neuropathy 83 (41.3) 6.14 (4.59) 172.41 (81.17)
Sexual dysfunction 69 (34.3) 4.70 (4.77) 162.29 (69.88)
Physical disability 132 (50.0) 5.80 (4.68) 169.61 (75.71)
Poor social support 95 (37.4) 7.44 (5.03) 167.47 (82.95)
Negative life event 88 (34.6) 6.64 (4.93) 168.75 (84.38)
Physical activity 55 (22%) 3.80 (3.53) 165.98 (82.69)
Perceived fear of complication and death 178 (70.1) 5.78 (4.74) 167.24 (71.88)
Perceived high health care cost of diabetes 192 (75.6) 5.35 (4.75) 168.15 (75.95)
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Table 2 Univariate linear regression test examining the association between biopsychosocial variables and PHQ-9 score 
of patients
Variables (reference category) β (95% CI) p value
Current age −0.03 (−0.08, 0.02) 0.21
Age at diagnosis −0.05 (−0.1, −0.001) 0.04
Female gender (male) 1.4 (0.4, 2.4) 0.01
Addis Ababa residence (outside Addis Ababa) −0.5 (−2.0, 1.0) 0.54
Monthly family income (ETB) −0.001 (−0.001, −0.0002) <0.001
Marital status (married)
 Divorced 2.2 (0.7, 3.7) 0.01
 Widowed 0.3 (−1.1, 1.6) 0.70
Religion (orthodox christian)
 Muslim −1.4 (−3.1, 0.3) 0.11
 Other religion −0.4 (−2.0, 1.3) 0.67
Ethnicity (others)
 Amhara −0.2 (−1.2, 0.8) 0.67
 Oromo 1.0 (−0.4, 2.4) 0.17
Educational status (no formal education)
 Primary school (1–8) 1.8 (0.7, 3.0) 0.002
 Secondary school (9–12) −0.7 (−1.9, 0.5) 0.23
 College/university −1.4 (−2.4, −0.3) 0.01
Occupation (others)
 Civil servant −0.7 (−2.0, 0.6) 0.28
 House wife 1.7 (0.4, 3.0) 0.01
 Private worker −0.8 (−2.2, 0.6) 0.26
 Pensioned −0.7 (−2.0, 0.5) 0.23
 No employment 1.1 (−0.7, 2.2) 0.10
Waist circumference 0.01 (−0.4, 0.1) 0.74
Duration of diabetes 0.03 (−0.03, 0.1) 0.35
Duration of diabetes treatment 0.03 (−0.04, 0.1) 0.36
Fasting blood glucose 0.01 (−0.001, 0.01) 0.09
Number of co-morbidity 0.6 (0.02, 1.1) 0.04
Number of prescribed medication administration per day 0.2 (−0.05, 0.4) 0.13
Number of diabetic complication 0.5 (0.1, 0.9) 0.02
Body mass index 0.1 (0.03, 0.3) 0.04
Combined insulin injection (single insulin injection) 1.0 (−1.9, 0.4) 0.42
Insulin injection plus oral hypoglycemic (single insulin injection) 0.3 (−1.3, 1.9) 0.72
Oral hypoglycemic agent (single insulin injection) −0.9 (−2.0, 0.1) 0.08
Cardiovascular disease 0.5 (−0.5, 1.5) 0.33
Respiratory disease 0.5 (−1.6, 2.5) 0.66
Renal disease 0.6 (−1.7, 2.9) 0.62
Neurologic disease 1.8 (−2.3, 5.9) 0.39
Others comorbidity 0.7 (−0.4, 1.8) 0.22
Diabetic retinopathy 1.0 (0.02, 2.0) 0.04
Diabetic nephropathy 2.0 (0.8, 3.1) 0.001
Diabetic neuropathy 1.1 (0.03, 2.2) 0.04
Sexual dysfunction −1.0 (−2.2, 0.1) 0.08
Physical disability 1.2 (0.2, 2.2) 0.02
Poor social support 3.1 (2.1, 4.1) <0.001
Doing physical activity −1.5 (−2.7, −0.3) 0.01
Fear of diabetic complication and death (no perception at all) 1.6 (0.6, 2.7) 0.003
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family conflicts and unavailability of food or medicines 
[16] were significant associated factors for depression.
Similar to previous studies [39, 58, 59, 67–70], our final 
model proved risk of depression was not significantly 
associated with current age, sex, educational status, resi-
dence, ethnicity, socioeconomic status, poor body weight 
control, insulin treatment users, duration of diabetes, 
obesity, hypertensive disorder, and diabetic retinopa-
thy. Recent studies [39–42, 47–49, 51, 66] found diabetic 
neuropathy, doing physical activity, diabetic retinopathy, 
educational status, perceived fear of diabetes-related 
death and complication, number of diabetic complica-
tion, being female, physical disability, increased body 
mass index, low monthly family income, age at diagnosis, 
and increased number of co-morbid disease significantly 
associated with depression. However, our study lacks to 
confirm this robust fact.
Most of these inconsistencies might be attributed to 
inadequacies in study design, implementation (i.e. data 
analysis and sample selection), interpretation (i.e. cat-
egorizing and using different cutoff point to diagnose 
depression), inadequately powered sample groups, and 
using different depression diagnostic tool. Using dichot-
omized PHQ-9 score as an outcome variable clearly 
causes loss of information, loss of power, bias, incom-
plete correction for confounding factors, and difficulty 
for robust replication of associated risk factors [71–73]. 
Similarly, Olivier Naggara and colleagues argued dichoto-
mization is unnecessary for statistical analysis, and con-
tinuous variable should be left alone in statistical model 
[74]. Researchers have used different cut-off point for 
dichotomizing PHQ-9 score [22, 59] that compromise 
replication for an unbiased view of the evidence from a 
particular study.
This study has important public health implication for 
health care practice in Black Lion General Specialized 
Hospital and another health facility, where clinician diag-
nosis of mental illness (depression) rate is low because of 
high patient load, lack of screening tool, role confusion, 
and lack of training. Another important barrier to the 
care of people with mental and physical health problem 
in lower and middle-income country is the lack of an 
integrated model for mental and medical health service 
[75]. We suggest physician or physiotherapist screen 
mental health and psychiatrist screen physical health 
of patient. Finally, clinicians should be aware of various 
factors and use biopsychosocial model to integrate their 
patient care.
Strengths and limitations
The strength of this study includes the use of PHQ-9 
score as continuous outcome variable. Variables were 
defined based on Engel’s biopsychosocial model as well. 
However, this study has certain limitation. Most param-
eters estimated were biologic (physiologic) factors. This 
might underestimate the effect of psychological and 
social factors. Poor social support, which was identified 
as a highly significant associated factor, was assessed by a 
single item. Additionally, this study was conducted in one 
institution that might limit external validity of the find-
ing. This study examined only the associations between 
the selected variables and PHQ-9 score. Lastly, the role 
Table 2 continued
Variables (reference category) β (95% CI) p value
Not fearing diabetic complication and death (no perception at all) −2.0 (−3.1, −0.9) <0.001
High health care cost (no perception at all) 0.4 (−0.7, 1.5) 0.50
Not high health care cost (no perception at all) −0.7 (−2.0, 0.5) 0.26
Negative life event in the last 6 months 2.0 (0.9, 2.9) <0.001
β regression coefficient; CI confidence interval
Table 3 Multiple linear regression test examining the relation between  different biopsychosocial associated factors 
and PHQ-9 score of patients with T2D mellitus
β regression coefficient; CI confidence interval
Variables β (95% CI) p value t value
Divorce 2.0 (0.6, 3.4) 0.004 2.91
Negative life event in the last 6 months 1.3 (0.3, 2.2) 0.009 2.63
House wife 1.7 (0.5, 2.8) 0.005 2.80
Diabetic nephropathy 1.5 (0.4, 2.5) 0.005 2.80
Poor social support 2.4 (1.5, 3.4) <0.001 5.07
Not fearing diabetic-related complications and death −1.5 (−2.5, −0.5) 0.003 −2.97
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of inflammation and genetic susceptibility for the emer-
gence of depressive symptoms was not assessed.
Conclusions
In general biopsychosocial variables including marital 
status, negative life event in the last six months, occu-
pational status, diabetic complication, and poor social 
support significantly increased risk of depression. Evi-
dence-based intervention focusing on these identified 
biopsychosocial factors are necessary to prevent the 
development of depressive symptoms. Our study find-
ing described the effect of various biopsychosocial fac-
tors on patient’s mood because depression-related factors 
frequently missed in people with diabetes [76]. This will 
improve evidence-based practice for comprehensive 
management physical and mental illness [77].
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